Loading...
The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions
The consensus Immunoscore is a routine assay quantifying the adaptive immune response within the tumor microenvironment. It has a prognostic value that has been confirmed in a phase 3 clinical trial (NCCTG N0147) in stage III colon cancers. Moreover, results from another phase 3 randomized trial rev...
Na minha lista:
| Udgivet i: | Oncoimmunology |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7466859/ https://ncbi.nlm.nih.gov/pubmed/32934890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1796003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|